Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
Chris Burggraeve is one of many entrepreneurs and investors increasingly flocking to the cannabis industry from the traditional business world
The price of bitcoin recently hit an all-time high of more than $7,800, edging closer to Goldman Sachs’ (NYSE: GS) forecast that the cryptocurrency will hit $8,000.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
PotNetwork Holding, Inc. (OTC: POTN) is in a strong position to take advantage of this market growth through its subsidiary, Diamond CBD.
A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018.
Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. has a potentially wide range of applications in the cannabis market.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool.
Investors interested in medicinal marijuana and/or Alzheimer’s treatments will find themselves looking at a global landscape of key players.
Skinvisible, Inc. (OTCQB: SKVI) is set for a business renaissance in the coming years.
On October 24, 2017, Grey Cloak Tech, Inc. announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products.
AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING).
These forward-thinking companies are developing proprietary systems and delivery methods to drive their research and development programs for a leading position in industry breakthroughs.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
Lexaria generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners.